Skip to main content

Month: September 2021

PARTS iD, Inc. Achieves 350% Growth within Original Equipment Parts Segment

Company onboarded products from nearly 34 major manufacturer brands including, Ram, Ford, Honda and Toyota CRANBURY, N.J., Sept. 08, 2021 (GLOBE NEWSWIRE) — PARTS iD, Inc. (NYSE American: ID) (“PARTS iD” or “Company”), the owner and operator of, among other verticals, “CARiD.com,” a leading digital commerce platform for the automotive aftermarket, today provided an update on its growth within the Original Equipment (OE) parts segment. OE parts, which are the same parts used to assemble the vehicle at the factory, continue to be a high-growth area for PARTS iD, with the Company reporting 350% OE business growth in H1 2021 compared to H1 2020. In 2020, the Company invested heavily into OE product cultivation, onboarding nearly 34 major manufacturer brands including Dodge, Jeep, Hyundai and Lexus. Following this successful expansion,...

Continue reading

InflaRx to Proceed with Pivotal Development for Vilobelimab in Hidradenitis Suppurativa with New Primary Endpoint

InflaRx received feedback from FDA within its Type A meeting which is supportive of a new primary endpoint measuring reductions in all three inflammatory HS lesions – including reductions of draining tunnels (previously referred to as draining fistulas) InflaRx will focus its pivotal development program on patients suffering from moderate to severe HS with active draining disease, as supported by the FDA InflaRx will incorporate FDA feedback in the study protocol for its pivotal program and submit the protocol in Q4 2021 with study activities to begin upon approval by FDAJENA, Germany, Sept. 08, 2021 (GLOBE NEWSWIRE) — InflaRx N.V. (Nasdaq: IFRX), a clinical-stage biopharmaceutical company developing anti-inflammatory therapeutics by targeting the complement system, announces its plan to proceed with a pivotal development program...

Continue reading

MIMEDX Announces Effectiveness of Shelf Registration Statement

MARIETTA, Ga., Sept. 08, 2021 (GLOBE NEWSWIRE) — MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”), an industry leader in utilizing amniotic tissue as a platform for regenerative medicine, today announced the shelf registration statement on Form S-3 on file with the Securities and Exchange Commission (SEC) has become effective. The shelf registration statement allows the Company to sell up to $350 million of various types of securities over the next three years. The specifics of any future offering, along with the prices and terms of any such securities and the use of proceeds of a particular offering, will be determined at the time of any such offering and will be described in a prospectus supplement filed in connection with such offering. Any offering of the securities will be made solely by means of a prospectus...

Continue reading

Monte Rosa Therapeutics to Participate in Morgan Stanley 19th Annual Global Healthcare Conference

BOSTON, Sept. 08, 2021 (GLOBE NEWSWIRE) — Monte Rosa Therapeutics, Inc. (NASDAQ: GLUE), a biotechnology company developing novel molecular glue precision medicines, today announced that Markus Warmuth, M.D., Chief Executive Officer, and Ajim Tamboli, CFA, Chief Financial Officer, are scheduled to participate in a virtual fireside chat at 2 p.m. ET on Wednesday, Sept. 15 at the Morgan Stanley 19th Annual Global Healthcare Conference. A live and archived webcast of the fireside chat will be available via the “Events & Presentations” section of the Company’s investors section of the website at https://ir.monterosatx.com/.        About Monte RosaMonte Rosa Therapeutics is a biotechnology company developing a portfolio of novel molecular glue degrader precision medicines. These medicines are designed to employ the body’s natural...

Continue reading

nCino Makes Commitment to Food Bank of Central & Eastern North Carolina

New Partnership Supports Development of Larger Facility to Address Food Insecurity in Wilmington Area WILMINGTON, N.C., Sept. 08, 2021 (GLOBE NEWSWIRE) — nCino, Inc. (NASDAQ: NCNO), a pioneer in cloud banking and digital transformation solutions for the global financial services industry, today announced its partnership with the Food Bank of Central & Eastern North Carolina in order to help the organization expand its food relief efforts and ensure substantial growth in its nutrition services, food access, and distribution throughout southeastern North Carolina. “The Food Bank at Wilmington is a valuable partner that provides a critical service for thousands of people in our area who suffer from food insecurity,” said Wilmington Mayor Bill Saffo. “From working families, to seniors on fixed incomes, to children and teens who...

Continue reading

Bolt Biotherapeutics Announces Clinical Collaboration with Bristol Myers Squibb to Study BDC-1001 in Combination with Opdivo® for Treatment of HER2-Expressing Solid Tumors

REDWOOD CITY, Calif., Sept. 08, 2021 (GLOBE NEWSWIRE) — Bolt Biotherapeutics, Inc. (Nasdaq: BOLT), a clinical-stage biotechnology company pioneering a new class of immuno-oncology agents that combine the targeting precision of antibodies with the power of both the innate and adaptive immune systems, today announced that it has entered into a clinical collaboration and supply agreement with Bristol Myers Squibb (NYSE: BMY) to investigate Bolt Biotherapeutics’ BDC-1001 in combination with Bristol Myers Squibb’s PD-1 checkpoint inhibitor Opdivo® (nivolumab). BDC-1001 is a HER2-targeting Boltbody™ immune-stimulating antibody conjugate (ISAC) in development for the treatment of patients with HER2-expressing solid tumors. “We look forward to working with BMS in our continued development of BDC-1001, which has shown promising results...

Continue reading

Lincoln Electric to Present at the Morgan Stanley 9th Annual Laguna Conference

CLEVELAND, Sept. 08, 2021 (GLOBE NEWSWIRE) — Lincoln Electric Holdings, Inc. (Nasdaq: LECO) today announced that Gabriel Bruno, Executive Vice President and Chief Financial Officer, will speak at the Morgan Stanley 9th Annual Laguna Conference being held virtually on Wednesday, September 15, 2021, at 1:30p.m. Eastern Time. The presentation will be webcast and can be accessed on our Investor Relations web site at https://ir.lincolnelectric.com. A replay will also be accessible on our Investor Relations web site. About Lincoln Electric Lincoln Electric is the world leader in the design, development and manufacture of arc welding products, automated joining, assembly and cutting systems, plasma and oxy-fuel cutting equipment, and has a leading global position in brazing and soldering alloys. Headquartered in Cleveland, Ohio, Lincoln...

Continue reading

Golden Tag Drills 75.89 g/t Ag.Eq over 274 m, Commencing Near Surface, and Confirms 500 m Vertical Extent Within the Newly Discovered 1849 Zone

Figure 1Plan View of Holes 21-57, 12-49, 07-18, 21-58Figure 2Oblique View to ENE of Key Results 21-57, 12-49, 07-18, 21-58Figure 3Oblique View to ENE of Holes 21-57,12-49, 07-18 and 21-58 with the 1849 & Fernandez ZonesFigure 4Plan View at 1000 mRL (650 m depth) of potential expansion of 1849 ZoneTORONTO, Sept. 08, 2021 (GLOBE NEWSWIRE) — Golden Tag Resources Ltd. (“Golden Tag” or the “Company“) (TSX.V: GOG) (OTCQB: GTAGF) is pleased to announce the complete results from diamond drillhole 21-57, part of an exploration program targeting bulk-tonnage mineralization on the Company’s 100% owned San Diego Project, located in Durango Mexico. Key highlights from hole 21-57 include:Commencing ~ 30 m below surface, well before the target area, hole 21-57...

Continue reading

Vivos Therapeutics to Participate at the H.C. Wainwright 23rd Annual Global Investment Conference

Vivos management to present at 7:00 am EDT on September 13, 2021 HIGHLANDS RANCH, Colo., Sept. 08, 2021 (GLOBE NEWSWIRE) — Vivos Therapeutics, Inc. (“the Company”) (NASDAQ: VVOS), a medical technology company focused on developing and commercializing innovative treatments for patients suffering from mild-to-moderate obstructive sleep apnea (OSA) and snoring, today announced that Kirk Huntsman, Chief Executive Officer, will be presenting at the H.C. Wainwright 23rd Annual Global Investment Conference at 7:00 am EDT on Monday, September 13, 2021. If you are an institutional or retail investor, and would like to listen to the Company’s presentation, please click on the following link (www.hcwevents.com/annualconference) to register for the conference. You may also listen to the company presentation online at: https://journey.ct.events/view/31441d30-9dd0-4c62-b9d9-8ac7be21c128 A...

Continue reading

Thryv survey finds concern among small businesses over COVID’s negative economic impact

Ongoing pandemic poses continued challenges for Main Street America Dallas, Sept. 08, 2021 (GLOBE NEWSWIRE) — Concern over the negative impacts of COVID remains high among America’s small businesses, with 82 percent reporting in a recent survey that they are at least “somewhat” concerned.  The survey, conducted by Thryv Holdings, Inc. (NASDAQ:THRY), the provider of Thryv® software, the end-to-end customer experience platform built for growing small businesses, polled over 750 owners and managers of small businesses. In addition to economic concerns, the survey also revealed that as vaccination rates across the U.S. grow, small businesses are debating whether to mandate vaccination among employees – with a majority (58 percent) responding that they do not plan to require vaccination.  Among the findings of the survey:60 percent...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.